Metraipolis › archive › dc_7dd73f41e758

High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights — Europe PMC PMID:41814015

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41814015
DOI
10.1038/s41375-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-11-04T13:26:35.353Z
SHA-256 of the archived text
d22755131e8194f9eb0f331b7c4d13688bc44cd2344a5e9d846ef26481a08aec
Stable URL of this page
https://metraipolis.com/documento/dc_7dd73f41e758

How to cite

High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights — Europe PMC PMID:41814015 — Europe PMC (en), https://europepmc.org/article/MED/41814015 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7dd73f41e758 (Metraipolis archive dc_7dd73f41e758, sha256 d22755131e8194f9eb0f331b7c4d13688bc44cd2344a5e9d846ef26481a08aec)
BibTeX
@misc{dc7dd73f41e758,
  title = {High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights — Europe PMC PMID:41814015},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41814015},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7dd73f41e758; sha256 d22755131e8194f9eb0f331b7c4d13688bc44cd2344a5e9d846ef26481a08aec},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41814015. Agents can read the archived copy with the MCP tool read_document.